Zenas BioPharma, Inc. (ZBIO) shareholders
Close on Nov 17, 2026Market cap $1.81BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| FMR LLC Joint filing with Abigail P. Johnson (14.30%) | 7,652,255 | 14.30% | 13G (passive) amendment | Dec 31, 2025 |
| InnoCare Pharma Limited Joint filing with InnoCare Pharma Inc. (10.40%), Ocean Prominent Limited (10.40%) | 7,000,000 | 10.40% | 13G (passive) amendment | Aug 26, 2026 |
| Wellington Investment Advisors Holdings LLP Joint filing with Wellington Management Group LLP (10.10%), Wellington Group Holdings LLP (10.10%) and 1 more | 6,566,134 | 10.10% | 13G (passive) | Aug 31, 2026 |
| Simeon George Joint filing with SR One Capital Management, LLC (7.70%) | 5,037,854 | 7.70% | 13D (active) amendment | Aug 13, 2026 |
| SR One Capital Management, LLC Joint filing with Simeon George (9.40%) | 5,037,854 | 9.40% | 13D (active) amendment | Oct 9, 2025 |
| Ocean Prominent Limited Joint filing with InnoCare Pharma Inc. (9.40%), InnoCare Pharma Limited (9.40%) | 5,000,000 | 9.40% | 13G (passive) | Oct 7, 2025 |
| Enavate Sciences GP, LLC Joint filing with Zebra Aggregator, LP (7.30%) | 3,919,159 | 7.30% | 13D (active) amendment | Oct 9, 2025 |
| Abigail P. Johnson Joint filing with FMR LLC (7.90%) | 3,323,534 | 7.90% | 13G (passive) amendment | Jun 30, 2025 |
| BlackRock, Inc. | 3,287,021 | 5.00% | 13G (passive) | Sep 30, 2026 |
| Moulder Leon O Jr | 3,220,880 | 5.09% | 13D (active) | Apr 29, 2026 |
| Rick Yang Joint filing with NEA 18 Venture Growth Equity, L.P. (6.60%), NEA Partners 18 VGE, L.P. (6.60%) and 8 more | 2,613,948 | 6.60% | 13G (passive) | Sep 16, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ZBIO | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 9,506,701 | 14.59% | $241.28M | +424,701 | 0.01% |
| Sr One Capital Management, LP | 5,037,854 | 7.73% | $127.86M | – | 12.31% |
| NEA Management Company, LLC | 4,023,219 | 6.17% | $102.11M | – | 6.43% |
| Enavate Sciences Gp, LLC | 3,919,159 | 6.01% | $99.47M | – | 28.80% |
| Federated Hermes, Inc. | 3,116,805 | 4.78% | $79.10M | −10,226 | 0.11% |
| BlackRock, Inc. | 2,686,225 | 4.12% | $68.18M | +648,677 | 0.00% |
| Capital International Investors | 2,502,912 | 3.84% | $63.52M | +68,912 | 0.01% |
| Polar Capital Holdings Plc | 2,412,772 | 3.70% | $61.24M | −135,672 | 0.14% |
| Royalty Pharma Sub-Manager, LLC | 2,388,150 | 3.66% | $60.61M | – | 25.05% |
| Fairmount Funds Management LLC | 2,359,025 | 3.62% | $59.87M | – | 3.96% |
| State Street Corp | 2,055,100 | 3.15% | $52.16M | +584,177 | 0.00% |
| NVP Associates, LLC | 1,838,482 | 2.82% | $46.66M | – | 14.22% |
| Wellington Management Group Llp | 1,593,819 | 2.45% | $40.45M | +347,766 | 0.01% |
| Vanguard Capital Management LLC | 1,354,864 | 2.08% | $34.39M | +109,473 | 0.00% |
| Bank Of America Corp /De/ | 1,231,159 | 1.89% | $31.25M | +842,812 | 0.00% |
| Price T Rowe Associates Inc /Md/ | 1,226,928 | 1.88% | $31.14M | +869,662 | 0.00% |
| Alliancebernstein L.P. | 1,103,388 | 1.69% | $21.57M | +206,067 | 0.01% |
| Geode Capital Management, LLC | 882,654 | 1.35% | $22.41M | +226,869 | 0.00% |
| Two Sigma Investments, LP | 815,150 | 1.25% | $20.69M | +540,094 | 0.01% |
| EcoR1 Capital, LLC | 789,500 | 1.21% | $20.04M | – | 0.97% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 145 | 61M | 94.0% | 29 / 62 | 39 / 22 | 7M | 4M |
| Q1 2026 | 140 | 58M | 88.7% | 51 / 58 | 17 / 28 | 20M | 3M |
| Q4 2025 | 119 | 43M | 65.7% | 47 / 37 | 24 / 8 | 11M | 3M |
| Q3 2025 | 80 | 35M | 53.4% | 14 / 24 | 20 / 7 | 2M | 2M |
| Q2 2025 | 73 | 34M | 52.3% | 11 / 34 | 12 / 5 | 2M | 1M |
| Q1 2025 | 67 | 32M | 49.8% | 13 / 14 | 21 / 10 | 3M | 2M |
| Q4 2024 | 65 | 32M | 48.7% | 35 / 13 | 7 / 14 | 9M | 2M |
| Q3 2024 | 44 | 25M | 38.0% | 44 / 0 | 0 / 0 | 25M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
163 funds held ZBIO in Q2 2026, 25% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ZBIO | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Health Care Fund | 2,937,055 | 4.51% | $92.34M | 0.24% | Jul 31, 2026 |
| SMALLCAP World Fund Inc | 2,434,000 | 3.73% | $61.77M | 0.07% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 1,349,396 | 2.07% | $34.25M | 0.32% | Jun 30, 2026 |
| Federated Hermes Kaufmann Fund | 1,330,000 | 2.04% | $41.82M | 0.85% | Jul 31, 2026 |
| Select Health Care Portfolio | 1,080,000 | 1.66% | $19.87M | 0.34% | May 31, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 1,008,169 | 1.55% | $18.55M | 0.01% | May 31, 2026 |
| Fidelity Small Cap Growth Fund | 988,639 | 1.52% | $31.08M | 0.35% | Jul 31, 2026 |
| Federated Hermes Kaufmann Small Cap Fund | 897,000 | 1.38% | $28.20M | 0.99% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 891,196 | 1.37% | $22.62M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 744,852 | 1.14% | $18.90M | 0.02% | Jun 30, 2026 |
| Fidelity Stock Selector Small Cap Fund | 662,841 | 1.02% | $20.84M | 0.28% | Jul 31, 2026 |
| Fidelity Small Cap Growth K6 Fund | 531,120 | 0.81% | $16.70M | 0.36% | Jul 31, 2026 |
| Fidelity Advisor Health Care Fund | 500,000 | 0.77% | $15.72M | 0.50% | Jul 31, 2026 |
| Fidelity Advisor Biotechnology Fund | 491,724 | 0.75% | $15.46M | 0.70% | Jul 31, 2026 |
| AB Small Cap Growth Portfolio | 467,848 | 0.72% | $11.87M | 0.38% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Leon O. Moulder Jr | See Remarks, Director | 520,083 | 0.80% | Jun 17, 2026 |
| Moltke Lisa von | See Remarks | – | – | Jun 17, 2026 |
| Joseph L. Farmer | See Remarks | 974 | 0.00% | Jun 17, 2026 |
| Jennifer A. Fox | See Remarks | 1,592 | 0.00% | Jun 17, 2026 |
| Orlando Oliveira | See Remarks | – | – | Jun 12, 2025 |
| Christy J. Oliger | Director | – | – | Sep 2, 2026 |
| John J. Orloff | Director | – | – | Jun 17, 2026 |
| Patrick G. Enright | Director | 1,844,659 | 2.83% | Jun 17, 2026 |
| Jason Raleigh Nunn | Director | 3,119,959 | 4.79% | Jun 17, 2026 |
| Patricia L. Allen | Director | 19,860 | 0.03% | Jun 17, 2026 |
| James P. Boylan | Director | – | – | Jun 17, 2026 |
| Hongbo Lu | Director | 426,736 | 0.65% | Jun 17, 2026 |
| Funds Management LLC Fairmount | Director | 1,892,806 | 2.90% | Apr 1, 2026 |
| Tomas Kiselak | Director | 2,359,025 | 3.62% | Apr 1, 2026 |
| Healthcare Fund II L.P. Fairmount | Director | 287,915 | 0.44% | Apr 1, 2026 |
| Peter Evan Harwin | Director | 2,209,025 | 3.39% | Apr 1, 2026 |
| Ting Xiao | Director | 10,000 | 0.02% | Apr 28, 2025 |
| Pharma Inc. InnoCare | 10% owner | 7,000,000 | 10.74% | Sep 8, 2026 |
| Simeon George | 10% owner | – | – | Oct 14, 2025 |
| Sr One Capital Management, Llc | 10% owner | 5,037,854 | 7.73% | Oct 14, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Leon O. Moulder Jr Chief Executive Officer, Director | May 18, 2026 | Buy | +60,000 | $16.88 | $1.01M | 96,928 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Apr 29, 2026 | Buy | +35,000 | $17.62 | $616.70K | 1,786,039 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Apr 28, 2026 | Buy | +25,000 | $18.02 | $450.50K | 1,751,039 |
| Hongbo Lu Director | Mar 31, 2026 | Buy | +3,768 | $18.63 | $70.20K | 426,736 |
| Tomas Kiselak Director | Mar 31, 2026 | Buy | +150,000 | $20.00 | $3.00M | 2,359,025 |
| Hongbo Lu Director | Mar 31, 2026 | Buy | +75,000 | $20.00 | $1.50M | 422,968 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Mar 31, 2026 | Buy | +34,000 | $19.31 | $656.54K | 1,726,039 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Mar 30, 2026 | Buy | +20,000 | $18.23 | $364.60K | 1,692,039 |
| Patricia L. Allen Director | Feb 13, 2026 | Buy | +4,160 | $26.36 | $109.66K | 19,860 |
| Patricia L. Allen Director | Feb 12, 2026 | Buy | +5,000 | $26.50 | $132.50K | 15,700 |
| Patricia L. Allen Director | Feb 12, 2026 | Buy | +5,000 | $23.77 | $118.85K | 5,000 |
| Patricia L. Allen Director | Feb 12, 2026 | Buy | +5,700 | $24.34 | $138.74K | 10,700 |
| Hongbo Lu Director | Feb 11, 2026 | Buy | +25,985 | $22.50 | $584.66K | 347,968 |
| Jennifer A. Fox See Remarks | Feb 5, 2026 | Award | +1,592 | $13.35 | $21.25K | 1,592 |
| Joseph L. Farmer See Remarks | Feb 5, 2026 | Award | +974 | $13.35 | $13.00K | 974 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Feb 2, 2026 | Buy | +57,000 | $17.96 | $1.02M | 423,155 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Jan 9, 2026 | Buy | +20,000 | $16.55 | $331.00K | 366,155 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Jan 8, 2026 | Buy | +30,000 | $16.30 | $489.00K | 346,155 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Jan 7, 2026 | Buy | +50,000 | $16.38 | $819.00K | 316,155 |
| Sr One Capital Management, Llc 10% owner | Oct 9, 2025 | Buy | +63,158 | $19.00 | $1.20M | 1,173,395 |
| Sr One Capital Management, Llc 10% owner | Oct 9, 2025 | Buy | +63,157 | $19.00 | $1.20M | 1,917,895 |
| Jason Raleigh Nunn Director | Oct 9, 2025 | Buy | +63,158 | $19.00 | $1.20M | 1,173,395 |
| Patrick G. Enright Director | Oct 9, 2025 | Buy | +11,990 | $20.85 | $249.99K | 11,990 |
| Patrick G. Enright Director | Oct 9, 2025 | Buy | +105,265 | $19.00 | $2.00M | 1,832,669 |
| Leon O. Moulder Jr See Remarks, Director | Oct 7, 2025 | Buy | +36,928 | $20.85 | $769.95K | 36,928 |
| Peter Evan Harwin Director | Oct 7, 2025 | Buy | +316,219 | $19.00 | $6.01M | 2,209,025 |
| Hongbo Lu Director | Oct 7, 2025 | Buy | +263,160 | $19.00 | $5.00M | 321,983 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Feb 18, 2025 | Buy | +25,000 | $6.67 | $166.75K | 266,155 |
| Ting Xiao Director | Feb 7, 2025 | Buy | +10,000 | $7.76 | $77.60K | 10,000 |
| Ting Xiao Director | Feb 7, 2025 | Buy | +10,000 | $7.76 | $77.60K | 47,000 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Dec 4, 2024 | Buy | +45,000 | $9.98 | $449.10K | 241,155 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Dec 3, 2024 | Buy | +25,000 | $10.76 | $269.00K | 196,155 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Nov 19, 2024 | Buy | +2,500 | $14.57 | $36.43K | 171,155 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Nov 18, 2024 | Buy | +7,500 | $15.00 | $112.50K | 168,655 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Sep 20, 2024 | Buy | +2,367 | $17.88 | $42.32K | 1,669,406 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Sep 20, 2024 | Buy | +2,633 | $18.97 | $49.95K | 1,672,039 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Sep 19, 2024 | Buy | +5,000 | $17.89 | $89.45K | 1,667,039 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Sep 18, 2024 | Buy | +10,000 | $17.91 | $179.10K | 1,662,039 |
| Zebra Aggregator, LP 10% owner | Sep 16, 2024 | Buy | +882,353 | $17.00 | $15.00M | 3,761,359 |
| Zebra Aggregator, LP 10% owner | Sep 16, 2024 | Conversion | +2,879,006 | – | – | 2,879,006 |
| Biomedical Innovation Master Investors (Cayman) I. L.P. Wellington 10% owner | Sep 16, 2024 | Conversion | +200,718 | – | – | 801,624 |
| Biomedical Innovation Master Investors (Cayman) I. L.P. Wellington 10% owner | Sep 16, 2024 | Conversion | +180,635 | – | – | 180,635 |
| Biomedical Innovation Master Investors (Cayman) I. L.P. Wellington 10% owner | Sep 16, 2024 | Conversion | +420,271 | – | – | 600,906 |
| Funds Management LLC Fairmount Director | Sep 16, 2024 | Buy | +300,000 | $17.00 | $5.10M | 1,892,806 |
| Funds Management LLC Fairmount Director | Sep 16, 2024 | Conversion | +41,130 | – | – | 329,045 |
| Funds Management LLC Fairmount Director | Sep 16, 2024 | Conversion | +252,890 | – | – | 581,935 |
| Funds Management LLC Fairmount Director | Sep 16, 2024 | Conversion | +301,077 | – | – | 1,592,806 |
| Funds Management LLC Fairmount Director | Sep 16, 2024 | Conversion | +709,794 | – | – | 1,291,729 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Sep 16, 2024 | Conversion | +372,017 | – | – | 1,652,039 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Sep 16, 2024 | Conversion | +164,523 | – | – | 1,280,022 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Sep 16, 2024 | Conversion | +108,381 | – | – | 112,901 |
| Leon O. Moulder Jr Chief Executive Officer, Director | Sep 16, 2024 | Conversion | +48,254 | – | – | 161,155 |
| Sr One Capital Management, Llc 10% owner | Sep 16, 2024 | Buy | +441,176 | $17.00 | $7.50M | 1,946,564 |
| Sr One Capital Management, Llc 10% owner | Sep 16, 2024 | Buy | +1,352,942 | $17.00 | $23.00M | 1,854,738 |
| Sr One Capital Management, Llc 10% owner | Sep 16, 2024 | Conversion | +1,505,388 | – | – | 1,505,388 |
| Sr One Capital Management, Llc 10% owner | Sep 16, 2024 | Buy | +441,176 | $17.00 | $7.50M | 1,110,237 |
| Sr One Capital Management, Llc 10% owner | Sep 16, 2024 | Conversion | +669,061 | – | – | 669,061 |
| Sr One Capital Management, Llc 10% owner | Sep 16, 2024 | Conversion | +501,796 | – | – | 501,796 |
| Peter Evan Harwin Director | Sep 16, 2024 | Conversion | +41,130 | – | – | 41,140 |
| Peter Evan Harwin Director | Sep 16, 2024 | Conversion | +252,890 | – | – | 294,020 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Zenas BioPharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 8,151 shares on Aug 26, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Zebra Aggregator, LP Affiliate | Aug 19, 2026 | 1,000,000 | $31.91M | Aug 19, 2026 | Series B |
See a number that looks wrong?